Related Experiment Video
Updated: Jan 14, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Sex differences in coronary artery disease
1Department of Cardiology and Angiology, Frankfurt University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. lena.seegers@unimedizin-ffm.de.
Insights
Myocardial infarction impacts both sexes, yet women face underdiagnosis and undertreatment. Addressing sex-specific cardiovascular disease risk factors is crucial for improving treatment outcomes in women.
Area of Science:
- Cardiology
- Cardiovascular Disease Research
- Women's Health
Background:
- Cardiovascular diseases, including myocardial infarction, are leading global causes of death.
- Women with cardiovascular diseases often experience underdiagnosis, undertreatment, and poorer outcomes compared to men.
- Significant sex-based differences exist in coronary artery disease presentation, diagnosis, and treatment.
Purpose of the Study:
- To highlight sex differences in cardiovascular disease, focusing on women.
- To review specific risk factors contributing to myocardial infarction in women.
- To inform pharmacological management strategies for coronary artery disease in women.
Main Methods:
- This is a review article.
- It synthesizes existing research on sex differences in cardiovascular disease.
- It examines the role of sex hormones, age-related cholesterol changes, and unique female risk factors.
Main Results:
- Women present with different symptoms, experience delays in emergency care, and often have non-obstructive coronary artery disease.
- Sex hormones influence hemostasis and increase bleeding risk post-intervention in women.
- Post-menopausal women and those with a history of hypertensive disorders of pregnancy face elevated myocardial infarction risk.
Conclusions:
- Pharmacological therapies for coronary artery disease prevention must account for sex-specific differences.
- Improving outcomes for women requires tailored approaches to diagnosis and treatment.
- Further research and clinical practice adjustments are needed to address the unique cardiovascular risks faced by women.
Abstract:
Myocardial infarction is the leading cause of death worldwide in men and in women. Nevertheless, cardiovascular diseases in women are still understudied, underdiagnosed and undertreated leading to poor outcomes and higher mortality rates. Important sex differences exist in coronary artery disease with a higher symptom burden, delayed presentation and treatment of women in the emergency department and more non-obstructive coronary artery disease on angiogram. Sex hormones influence hemostasis and platelet function, and women suffer more from major bleeding complications after coronary interventions. Moreover, cholesterol levels increase with age particularly in women and sex hormones might play an important role in the development and progression of atherosclerosis with an increasing cardiovascular risk for women after menopause. Women also have other unique sex-specific risk factors such as hypertensive disorders of pregnancy that are contributing to an increased risk of myocardial infarction. Therefore, pharmacological therapies regarding primary or secondary prevention of coronary artery disease need to address sex differences to improve female outcome in the future. This review highlights these differences and specific risk factors in women to consider in pharmacological management of coronary artery disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...

